Patients with cancers of the head and neck who received intensity-modulated radiation therapy (IMRT) – a technology designed to more precisely target cancer cells and spare nearby tissue – experienced improved outcomes, as well as reduced toxicities, compared to patients receiving conventional radiation therapy, according to new research.